Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | LIN28A | Q9H9Z2 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | APP | P05067 | 1/20 | 0.46 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | SLC1A5 | Q15758 | 1/20 | 0.40 |
| ▸ | HRH1 | P35367 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16590461 | 1.00 | MAPT (0.59) | MAPTSMN1; SMN2LIN28ATDP1ALDH1A1 | |
| SCHEMBL31404243 | 1.00 | MAPT (0.59) | MAPTSMN1; SMN2LIN28ATDP1ALDH1A1 | |
| SCHEMBL31171933 | 0.93 | MAPT (0.71) | MAPTSMN1; SMN2LIN28ATDP1ALDH1A1 | |
| SCHEMBL13555815 | 0.91 | MAPT (0.53) | MAPTSMN1; SMN2LIN28ATDP1ALDH1A1 | |
| SCHEMBL15483869 | 0.87 | MAPT (0.46) | MAPTSMN1; SMN2LIN28ATDP1ALDH1A1 | |
| SCHEMBL14369562 | 0.86 | MAPT (0.59) | MAPTSMN1; SMN2LIN28ATDP1APP | |
| SCHEMBL16154021 | 0.86 | MAPT (0.51) | MAPTSMN1; SMN2LIN28ATDP1ALDH1A1 | |
| SCHEMBL23204338 | 0.85 | MAPT (0.47) | MAPTSMN1; SMN2LIN28ATDP1ALDH1A1 | |
| SCHEMBL16099570 | 0.85 | CYP1A2 (0.51) | MAPTSMN1; SMN2LIN28ATDP1ALDH1A1 | |
| SCHEMBL15483577 | 0.84 | MAPT (0.43) | MAPTSMN1; SMN2LIN28ATDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5850086-A | Iron complexes for bleach activation and stereospecific oxidation | REGENTS OF THE UNIVERSITY OF MINNESOTA | 1998-12-15 | — | — | US | claimed |
| WO-1997048710-A1 | IRON COMPLEXES FOR BLEACH ACTIVATION AND STEREOSPECIFIC OXIDATION | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1997-12-24 | — | — | WO | claimed |
| US-20250206704-A1 | ENGINEERED IONOPHORES FOR TRANSPORT OF METAL IONS | NATIONAL INSTITUTES OF HEALTH | 2025-06-26 | — | — | US | disclosed |
| WO-2023183559-A1 | ENGINEERED IONOPHORES FOR TRANSPORT OF METAL IONS | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2023-09-28 | — | — | WO | disclosed |
| WO-2023183559-A1 | ENGINEERED IONOPHORES FOR TRANSPORT OF METAL IONS | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2023-09-28 | — | — | WO | disclosed |
| US-9593138-B2 | Nitrile-containing enzyme inhibitors and ruthenium complexes thereof | WAYNE STATE UNIVERSITY (US) | 2017-03-14 | — | — | US | disclosed |
| US-9533297-B2 | Ligands designed to provide highly active catalyst complexes | CARNEGIE MELLON UNIVERSITY (US) | 2017-01-03 | — | — | US | disclosed |
| US-20150087795-A1 | LIGANDS DESIGNED TO PROVIDE HIGHLY ACTIVE CATALYST COMPLEXES | CARNEGIE MELLON UNIVERSITY | 2015-03-26 | — | — | US | disclosed |
| US-8338600-B2 | Copper-oxygen adduct complexes, and methods of making and use | JUSTUS-LIEBIG-UNIVERSITAT GIESSEN (DE) | 2012-12-25 | — | — | US | disclosed |
| EP-2215096-B1 | COPPER-OXYGEN ADDUCT COMPLEXES | UNIV GIESSEN JUSTUS LIEBIG (DE) | 2012-09-19 | — | — | EP | disclosed |
| US-20120016127-A1 | COPPER-OXYGEN ADDUCT COMPLEXES | JUSTUS-LIEBIG-UNIVERSITAET GIESSEN (DE) | 2012-01-19 | — | — | US | disclosed |
| EP-2215096-A1 | COPPER-OXYGEN ADDUCT COMPLEXES | Justus-Liebig-Universität Gießen (DE) | 2010-08-11 | — | — | EP | disclosed |
| WO-2009052809-A1 | COPPER-OXYGEN ADDUCT COMPLEXES | JUSTUS-LIEBIG-UNIVERSITÄT GIESSEN (DE) | 2009-04-30 | — | — | WO | disclosed |
| US-6107528-A | BLEACH AND OXIDATION CATALYST IS PROVIDED COMPRISING A CATALYTICALLY ACTIVE IRON COMPLEX WHICH CAN ACTIVATE HYDROGEN PEROXIDE OR PEROXY ACIDS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2000-08-22 | — | — | US | disclosed |
| US-5850086-A | Iron complexes for bleach activation and stereospecific oxidation | REGENTS OF THE UNIVERSITY OF MINNESOTA | 1998-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250206704-A1 | ENGINEERED IONOPHORES FOR TRANSPORT OF METAL IONS | SLC7A1, SLC47A2, SLC39A14 | MAPT 3571/4885SMN1; SMN2 4138/4885LIN28A 2497/4885 |
| US-20120016127-A1 | COPPER-OXYGEN ADDUCT COMPLEXES | AOC2, AOC3, AOC1 | MAPT 2441/4885SMN1; SMN2 3131/4885LIN28A 2311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.